Results for tag: "Vismodegib"

Vismodegib is a drug used to treat advanced basal cell carcinoma (BCC), a type of skin cancer. It is a hedgehog pathway inhibitor, meaning it blocks a signal pathway that is involved in the growth and spread of cancer cells. Vismodegib is taken orally and is usually prescribed when other treatments, such as surgery, have not been successful. It is approved for use in adults and is the only drug of its kind available in the United States. Vismodegib is marketed by Genentech, a subsidiary of Roche, and is available in the United States, Canada, and Europe. Other companies involved in the market include Novartis, which has a licensing agreement with Genentech, and Merck, which is developing a similar drug. Additionally, several generic versions of the drug are available in some countries. Companies in the Vismodegib market include Genentech, Novartis, Merck, and generic drug manufacturers. Show Less Read more